Austrian PIUR IMAGING Secures €5.6 Million Funding To Scale Tomographic 3D Ultrasound Globally

The round was led by Aescuvest Capital Partners, a top healthcare investor from Germany.

“Ultrasound is one of the most valuable imaging modalities – flexible, safe, and affordable. But its greatest limitation remains user-dependency, as most conclusions are drawn from 2D slices that vary by operator,” said Frederik Bender, Managing Director & CEO of PIUR IMAGING. “By adding a third dimension, we eliminate much of that variability – shifting from subjective snapshots to comprehensive, organ-level imaging that enables AI to perform more consistent and reliable analysis.

“This investment allows us to bring this vision to scale. It empowers us to grow our commercial footprint especially in the U.S., expand our product integration with global ultrasound leaders, and continue developing clinical applications that improve patient outcomes. We’re not just adding technology – we’re changing the standard of care.”

Founded in 2014, PIUR IMAGING is an ISO-13485 certified and FDA-approved medical device company that focuses on advanced 3D ultrasound technology. Their goal is to improve diagnosis and patient care by upgrading existing 2D ultrasound machines with their innovative add-on solutions.

Read Also - Dutch Startup QuiX Quantum Raises €15 Million In Series A Round

Their unique sensor turns regular 2D ultrasounds into high-quality 3D imaging tools, allowing full organs and body structures to be scanned in one go. With AI-powered analysis and volume measurements, doctors can make faster, more accurate, and consistent diagnoses across many medical fields.

“PIUR’s approach is elegant in its simplicity. Rather than reinventing the wheel, they unlock new value from existing ultrasound systems with a seamless add-on solution,” said Christoph Bartoschek, Investment Principal at Aescuvest Capital Partners. “This lowers the adoption barrier significantly – users understand it immediately, and the clinical benefits are clear.”

With recent FDA approval and the launch of its U.S. subsidiary, PIUR IMAGING plans to use the new funding to expand its business in the American market. The company’s growth will focus on two main products: PIUR tUS Infinity, an add-on that upgrades any 2D ultrasound machine into a 3D device, and PIUR tUS inside, a built-in solution integrated into select GE HealthCare LOGIQ scanners.

“What excites us as investors is the clarity of the value proposition and the company’s strong foundation. PIUR has already built a loyal customer base in the DACH region, signed agreements with respected partners in the imaging ecosystem, and assembled a team with a focused vision for scaling across clinical indications and geographies.

“The recent FDA clearance of the tUS inside makes this an ideal time to invest aligning perfectly with our strategy of targeting opportunities approaching key regulatory milestones,” Bartoschek added.

As global healthcare systems work to enhance diagnostic access and efficiency, PIUR’s tomographic 3D ultrasound provides a powerful and potentially game-changing solution.

About PIUR IMAGING

Founded in 2014 Austria-based PIUR IMAGING specializes in 3D ultrasound imaging. Their AI-powered solution, PIUR tUS Infinity, transforms any standard 2D ultrasound into a 3D system, enabling clearer, retrospective diagnoses. It improves thyroid analysis and streamlines workflows making high-quality healthcare more accessible and less dependent on operator expertise.